The living donor experience

Donor health assessment and outcomes after living donor liver transplantation

Kimberly L. Beavers, Robert S. Sandler, Jeffrey Fair, Mark W. Johnson, Roshan Shrestha

Research output: Contribution to journalArticle

128 Citations (Scopus)

Abstract

Despite the increasing use of living donor liver transplantation, little is known about donor needs, concerns, and experiences. The goal of this study is to assess morbidity associated with living donation from a donor perspective, functional status after donation, and overall satisfaction with the donation process. We surveyed all living donors (LDs) from our center. Demographics, perioperative experience, and satisfaction with donation were assessed. The Medical Outcomes Study 12-Item Short-Form Survey (SF-12), a well-validated tool, measured overall health-related quality of life. Of 27 subjects eligible for the study, 27 subjects (100%) participated. Forty percent reported an event they deemed an immediate complication, of which 60% were recorded in the medical record. Complications requiring readmission were reported by 22%. Mean recovery time was 12 weeks (range, 1 to 52 weeks). No significant change was reported in physical activity, social activity, or emotional stability, and 92% of donors resumed their predonation occupation. Regardless of recipient outcome, 100% of donors would donate again and recommend donation to someone in contemplation. All surveyed LDs at our institution are satisfied with their donation decision. Morbidity in the first year after donation may be greater than previously appreciated. Despite complications, postoperative functional status of donors is equal to or better than population norms.

Original languageEnglish (US)
Pages (from-to)943-947
Number of pages5
JournalLiver Transplantation
Volume7
Issue number11
DOIs
StatePublished - 2001
Externally publishedYes

Fingerprint

Living Donors
Liver Transplantation
Outcome Assessment (Health Care)
Tissue Donors
Health
Morbidity
Occupations
Medical Records
Quality of Life
Demography
Exercise
Population

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

The living donor experience : Donor health assessment and outcomes after living donor liver transplantation. / Beavers, Kimberly L.; Sandler, Robert S.; Fair, Jeffrey; Johnson, Mark W.; Shrestha, Roshan.

In: Liver Transplantation, Vol. 7, No. 11, 2001, p. 943-947.

Research output: Contribution to journalArticle

Beavers, Kimberly L. ; Sandler, Robert S. ; Fair, Jeffrey ; Johnson, Mark W. ; Shrestha, Roshan. / The living donor experience : Donor health assessment and outcomes after living donor liver transplantation. In: Liver Transplantation. 2001 ; Vol. 7, No. 11. pp. 943-947.
@article{71a3403e55a546f1a153a4516e35ec35,
title = "The living donor experience: Donor health assessment and outcomes after living donor liver transplantation",
abstract = "Despite the increasing use of living donor liver transplantation, little is known about donor needs, concerns, and experiences. The goal of this study is to assess morbidity associated with living donation from a donor perspective, functional status after donation, and overall satisfaction with the donation process. We surveyed all living donors (LDs) from our center. Demographics, perioperative experience, and satisfaction with donation were assessed. The Medical Outcomes Study 12-Item Short-Form Survey (SF-12), a well-validated tool, measured overall health-related quality of life. Of 27 subjects eligible for the study, 27 subjects (100{\%}) participated. Forty percent reported an event they deemed an immediate complication, of which 60{\%} were recorded in the medical record. Complications requiring readmission were reported by 22{\%}. Mean recovery time was 12 weeks (range, 1 to 52 weeks). No significant change was reported in physical activity, social activity, or emotional stability, and 92{\%} of donors resumed their predonation occupation. Regardless of recipient outcome, 100{\%} of donors would donate again and recommend donation to someone in contemplation. All surveyed LDs at our institution are satisfied with their donation decision. Morbidity in the first year after donation may be greater than previously appreciated. Despite complications, postoperative functional status of donors is equal to or better than population norms.",
author = "Beavers, {Kimberly L.} and Sandler, {Robert S.} and Jeffrey Fair and Johnson, {Mark W.} and Roshan Shrestha",
year = "2001",
doi = "10.1053/jlts.2001.28443",
language = "English (US)",
volume = "7",
pages = "943--947",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "11",

}

TY - JOUR

T1 - The living donor experience

T2 - Donor health assessment and outcomes after living donor liver transplantation

AU - Beavers, Kimberly L.

AU - Sandler, Robert S.

AU - Fair, Jeffrey

AU - Johnson, Mark W.

AU - Shrestha, Roshan

PY - 2001

Y1 - 2001

N2 - Despite the increasing use of living donor liver transplantation, little is known about donor needs, concerns, and experiences. The goal of this study is to assess morbidity associated with living donation from a donor perspective, functional status after donation, and overall satisfaction with the donation process. We surveyed all living donors (LDs) from our center. Demographics, perioperative experience, and satisfaction with donation were assessed. The Medical Outcomes Study 12-Item Short-Form Survey (SF-12), a well-validated tool, measured overall health-related quality of life. Of 27 subjects eligible for the study, 27 subjects (100%) participated. Forty percent reported an event they deemed an immediate complication, of which 60% were recorded in the medical record. Complications requiring readmission were reported by 22%. Mean recovery time was 12 weeks (range, 1 to 52 weeks). No significant change was reported in physical activity, social activity, or emotional stability, and 92% of donors resumed their predonation occupation. Regardless of recipient outcome, 100% of donors would donate again and recommend donation to someone in contemplation. All surveyed LDs at our institution are satisfied with their donation decision. Morbidity in the first year after donation may be greater than previously appreciated. Despite complications, postoperative functional status of donors is equal to or better than population norms.

AB - Despite the increasing use of living donor liver transplantation, little is known about donor needs, concerns, and experiences. The goal of this study is to assess morbidity associated with living donation from a donor perspective, functional status after donation, and overall satisfaction with the donation process. We surveyed all living donors (LDs) from our center. Demographics, perioperative experience, and satisfaction with donation were assessed. The Medical Outcomes Study 12-Item Short-Form Survey (SF-12), a well-validated tool, measured overall health-related quality of life. Of 27 subjects eligible for the study, 27 subjects (100%) participated. Forty percent reported an event they deemed an immediate complication, of which 60% were recorded in the medical record. Complications requiring readmission were reported by 22%. Mean recovery time was 12 weeks (range, 1 to 52 weeks). No significant change was reported in physical activity, social activity, or emotional stability, and 92% of donors resumed their predonation occupation. Regardless of recipient outcome, 100% of donors would donate again and recommend donation to someone in contemplation. All surveyed LDs at our institution are satisfied with their donation decision. Morbidity in the first year after donation may be greater than previously appreciated. Despite complications, postoperative functional status of donors is equal to or better than population norms.

UR - http://www.scopus.com/inward/record.url?scp=0035183356&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035183356&partnerID=8YFLogxK

U2 - 10.1053/jlts.2001.28443

DO - 10.1053/jlts.2001.28443

M3 - Article

VL - 7

SP - 943

EP - 947

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 11

ER -